Aptar Pharma and Aceso Therapeutics Collaborate to Advance Inhaled ASO Therapy for Cystic Fibrosis Aptar Pharma, a global provider of drug delivery, dosing, protection technologies and development services, has announced a new collaboration with Aceso Therapeutics, a biotechnology company focused…
Segal Trials Employees Join CISCRP Medical Heroes Appreci-A-Thon to Honor Clinical Research Participants and Professionals More than 90 employees from Segal Trials are participating in the 8th Annual Medical Heroes Appreci-A-Thon organized by the Center for Information and Study on…
Biocytogen and Qilu Pharmaceutical Enter Non-Exclusive Licensing Agreement for Fully Human VHH Antibody in Neuroscience Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SSE: 688796; HKEX: 02315), a biotechnology company focused on the discovery and development of innovative antibody-based therapeutics, has entered into…
Huonslab Expands Intellectual Property Portfolio for HyDIFFUZE™ Platform to Advance Subcutaneous Biologic Drug Delivery Huonslab, the research and development subsidiary of Huons Global (KOSDAQ: 084110), has strengthened its position in the rapidly evolving biologics market by securing new intellectual property…
Logan University Health Centers and Arete Healthcare Partner to Expand Patient Access and Modernize Clinical Care Logan University Health Centers has announced a strategic partnership with Arete Healthcare aimed at expanding access to healthcare, improving clinical operations, and creating stronger…
New Study in Neurology Highlights the Potential of Quantitative MRI Biomarkers for Assessing Muscle Changes in SBMA AMRA Medical has announced the publication of new research in Neurology demonstrating the potential of quantitative whole-body magnetic resonance imaging (MRI) to measure…
Lōkahi Therapeutics Begins GMP Manufacturing of LT-100 for Potential Osteoarthritis Pain Treatment Lōkahi Therapeutics Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), has announced the initiation of its initial Good Manufacturing Practice (GMP) manufacturing campaign for LT-100, a pure honeybee…
Ivonescimab Plus Chemotherapy Phase III HARMONi Results Published in The Lancet Oncology Summit Therapeutics Inc. has announced the publication of primary analysis results from its global Phase III HARMONi clinical trial in The Lancet Oncology, providing peer-reviewed evidence supporting the…
Copia Scientific and HSE•AG Partner to Expand On-Deck Nucleic Acid Quantification for Laboratory Automation Copia Scientific, a provider of laboratory automation, equipment, integration and technical service solutions, has announced a new distribution agreement with HSE•AG, a Switzerland-based developer and manufacturer…
Spruce Biosciences Advances Toward 2026 BLA Submission for Tralesinidase Alfa in Sanfilippo Syndrome Type B Spruce Biosciences, Inc., a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies for neurological disorders with significant unmet medical needs, has announced important…
TwinStrand Biosciences Secures More Than $245 Million Judgment in Patent Infringement Case Against Guardant Health TwinStrand Biosciences, Inc., the developer of Duplex Sequencing® technology, announced that the U.S. District Court for the District of Delaware entered a final judgment on…
AbbVie Highlights New Lung Cancer Research Data Across NSCLC and SCLC Programs at WCLC 2026 AbbVie is showcasing a broad collection of new research findings across its lung cancer development portfolio at the 2026 World Conference on Lung Cancer (WCLC),…